The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence

aRheumatology Department, Centra Hospitalar e Universitário de Coimbra

bFaculty of Medicine, University of Coimbra, Coimbra, Portugal

cDepartment of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam

dAmsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

eDivision of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics University of Alabama at Birmingham, Birmingham, Alabama, USA

fDepartment of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany

gCoimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal

Correspondence to José A.P. da Silva, Rheumatology Department, Centra Hospitalar e Universitário de Coimbra, Praceta Professor Mota Pinto, 3000-076 Coimbra, Portugal. Tel: +351 239 400 547; e-mail: [email protected]

留言 (0)

沒有登入
gif